NURS FPX 4045 Assessment 3 Evidence-Based Proposal and Annotated Bibliography on Technology in Nursing

Student Name

Capella University

NURS-FPX 4045 Assessment 3

Professor Name

Submission Date

Evidence-Based Proposal and Annotated Bibliography on Technology in Nursing

Introduction

Healthcare technology continues to transform nursing practice by improving patient safety, enhancing quality of care, and promoting efficient interdisciplinary collaboration. One technology that has significantly improved diabetes management is insulin pump technology. Insulin pumps provide continuous subcutaneous insulin infusion, enabling precise insulin delivery and improved glycemic control for individuals with diabetes. As chronic diseases continue to increase across the United States, healthcare organizations are increasingly adopting advanced technologies to support patient-centered care and improve clinical outcomes.

Insulin pump technology supports real-time monitoring, individualized treatment plans, and enhanced patient self-management. Furthermore, integration with continuous glucose monitoring (CGM) systems, telehealth platforms, and artificial intelligence (AI)-driven decision-support tools has expanded the effectiveness of insulin pump therapy. This proposal examines the impact of insulin pump technology on patient safety, quality of care, and interdisciplinary collaboration while presenting an annotated bibliography of current evidence supporting its implementation in healthcare organizations.

Rationale for Selecting Insulin Pump Technology

Insulin pump technology was selected because of its growing importance in chronic disease management and its ability to improve patient outcomes through precise insulin administration. Diabetes affects millions of individuals worldwide and remains a leading cause of cardiovascular disease, kidney failure, blindness, and lower-extremity amputations. Effective glucose management is essential to reducing these complications and improving quality of life.

Modern insulin pumps offer numerous advantages compared to traditional insulin injection methods. These devices continuously deliver basal insulin while allowing patients to administer bolus doses based on carbohydrate intake and blood glucose levels. Many current-generation pumps integrate with continuous glucose monitoring systems to create automated insulin delivery systems capable of adjusting insulin administration based on real-time glucose readings.

The literature review focused on peer-reviewed articles published between 2020 and 2025. Databases used included PubMed, Elsevier, Journal of Managed Care & Specialty Pharmacy, Journal of the American Medical Association (JAMA), and Pharmaceutics. Search terms included:

Insulin pump technology
Diabetes management
Telehealth nursing
Artificial intelligence and diabetes
Remote patient monitoring
Continuous glucose monitoring
Nurse-led diabetes interventions

The selected studies provide evidence regarding patient safety, quality outcomes, interdisciplinary collaboration, organizational implementation, and technological innovations associated with insulin pump therapy.

Annotated Bibliography

Impact on Patient Safety and Quality of Care

Rimon, M. T. I., Hasan, M. W., Hassan, M. F., & Cesmeci, S. (2024)

Reference

Rimon, M. T. I., Hasan, M. W., Hassan, M. F., & Cesmeci, S. (2024). Advancements in insulin pumps: A comprehensive exploration of insulin pump systems, technologies, and future directions. Pharmaceutics, 16(7), 944. https://doi.org/10.3390/pharmaceutics16070944

Annotation

This comprehensive review examines recent advancements in insulin pump technologies, including automated insulin delivery systems, continuous glucose monitoring integration, wireless connectivity, and artificial intelligence-supported algorithms. The authors discuss how these innovations improve glycemic control while reducing episodes of severe hypoglycemia and hyperglycemia.

The article demonstrates that advanced insulin pump systems significantly enhance patient safety by providing real-time glucose monitoring and automated insulin adjustments. These technologies help prevent medication errors and reduce acute diabetic complications. The review also highlights the importance of interdisciplinary collaboration among nurses, endocrinologists, diabetes educators, pharmacists, and information technology specialists during implementation and ongoing management.

This source is valuable because it provides a current overview of emerging insulin pump technologies and identifies opportunities for nursing professionals to support patient education, device monitoring, and chronic disease management.

Integration of Telehealth and Nursing Practice

Piotie, P. N., Wood, P., Muchiri, J. W., Webb, E. M., & Rheeder, P. (2022)

Reference

Piotie, P. N., Wood, P., Muchiri, J. W., Webb, E. M., & Rheeder, P. (2022). Using a nurse-driven and home-based telehealth intervention to improve insulin therapy for people with type 2 diabetes in primary care: A feasibility study. Journal of Endocrinology, Metabolism and Diabetes of South Africa, 27(3), 108–116. https://doi.org/10.1080/16089677.2022.2074122

Annotation

This study evaluates a nurse-led telehealth intervention designed to support insulin therapy management among adults with type 2 diabetes. Participants received remote monitoring, virtual consultations, and ongoing education regarding insulin use and self-management strategies.

The findings indicate that telehealth-supported insulin management improved patient engagement, treatment adherence, and glycemic control. Nurses played a central role in identifying potential complications, monitoring insulin use, and providing timely interventions. The study demonstrates how technology can strengthen patient-provider communication while supporting safe and effective diabetes management.

The article is particularly relevant because it highlights the expanding role of nurses in remote patient monitoring and telehealth-based chronic disease management.

Organizational Factors Affecting Technology Adoption

Puckett, C., Wong, J. C., Daley, T., & Cossen, K. (2020)

Reference

Puckett, C., Wong, J. C., Daley, T., & Cossen, K. (2020). How organizations shape medical technology allocation: Insulin pumps and pediatric patients with type 1 diabetes. Social Science & Medicine, 249, 112825. https://doi.org/10.1016/j.socscimed.2020.112825

Annotation

This qualitative study explores how healthcare organizations influence insulin pump allocation decisions among pediatric patients with type 1 diabetes. Through interviews and observational research, the authors examined organizational culture, decision-making structures, and technology adoption practices.

The study found that organizational leadership, provider attitudes, resource availability, and institutional policies significantly impact patient access to insulin pump technology. Clinics with supportive organizational cultures demonstrated higher rates of technology adoption and more equitable access to advanced diabetes care.

This source emphasizes the importance of leadership support, organizational readiness, and evidence-based decision-making when implementing new healthcare technologies.

Impact on Healthcare Utilization and Patient Outcomes

Biskupiak, J. E., Carlow, D. L., & Munshi, M. N. (2024)

Reference

Biskupiak, J. E., Carlow, D. L., & Munshi, M. N. (2024). Impact of a tubeless, disposable insulin pump on emergency department visits and inpatient admissions among a Medicare population. Journal of Managed Care & Specialty Pharmacy, 30(10), 1–8. https://doi.org/10.18553/jmcp.2024.23292

Annotation

This retrospective observational study investigated healthcare utilization among Medicare beneficiaries using a tubeless insulin pump system. Researchers compared emergency department visits and inpatient admissions before and after insulin pump implementation.

Results demonstrated reductions in diabetes-related emergency department visits and hospital admissions following adoption of the insulin pump system. Improved glycemic control and enhanced treatment adherence contributed to these positive outcomes.

The findings suggest that insulin pump technology can reduce healthcare costs while improving patient safety and quality of care. This study supports organizational investment in advanced diabetes technologies as a strategy to improve outcomes and decrease resource utilization.

Artificial Intelligence and Diabetes Management

Nayak, A., Vakili, S., Nayak, K., Nikolov, M., Chiu, M., Sosseinheimer, P., et al. (2023)

Reference

Nayak, A., Vakili, S., Nayak, K., Nikolov, M., Chiu, M., Sosseinheimer, P., Talamantes, S., Testa, S., Palanisamy, S., Giri, V., & Schulman, K. (2023). Use of voice-based conversational artificial intelligence for basal insulin prescription management among patients with type 2 diabetes: A randomized clinical trial. JAMA Network Open, 6(12), e2340232. https://doi.org/10.1001/jamanetworkopen.2023.40232

Annotation

This randomized clinical trial evaluated the effectiveness of voice-based artificial intelligence in managing basal insulin prescriptions for patients with type 2 diabetes. The AI system provided automated insulin titration guidance and monitored patient adherence.

The study found that AI-assisted management improved treatment efficiency, medication adherence, and glycemic outcomes without increasing adverse events. Patients achieved insulin dose adjustments more rapidly compared to traditional provider-managed approaches.

This source demonstrates the growing potential of artificial intelligence to support nursing practice, improve clinical decision-making, and enhance chronic disease management. AI technologies can assist nurses by identifying trends, detecting potential complications, and facilitating timely interventions.

Evidence-Based Recommendations

The evidence consistently supports the implementation of insulin pump technology within healthcare organizations. Several recommendations emerge from the literature:

Improve Patient Safety

Healthcare organizations should implement advanced insulin pump systems integrated with continuous glucose monitoring technologies. Automated insulin delivery systems reduce medication errors, improve glycemic control, and decrease acute diabetic complications.

Expand Telehealth Integration

Nurse-led telehealth programs should be incorporated into diabetes management strategies. Remote monitoring and virtual consultations improve treatment adherence, increase patient engagement, and facilitate early intervention when complications arise.

Strengthen Organizational Support

Successful technology adoption requires leadership commitment, adequate funding, staff training, and supportive organizational policies. Healthcare organizations should create implementation plans that promote equitable access to insulin pump technology.

Utilize Artificial Intelligence Tools

AI-supported insulin management systems can enhance efficiency and improve patient outcomes. Healthcare organizations should explore opportunities to integrate AI technologies into diabetes care programs while maintaining appropriate clinical oversight.

Enhance Interdisciplinary Collaboration

Effective insulin pump implementation requires collaboration among nurses, physicians, diabetes educators, pharmacists, information technology specialists, and organizational leaders. Interdisciplinary teamwork supports safe device utilization and improved patient outcomes.

Conclusion

Insulin pump technology represents a significant advancement in diabetes management and nursing practice. Evidence demonstrates that insulin pumps improve glycemic control, reduce hospitalizations, enhance patient safety, and support patient-centered care. Integration with telehealth services, artificial intelligence systems, and continuous glucose monitoring technologies further strengthens the effectiveness of this intervention.

Healthcare organizations that invest in insulin pump technology can achieve improved clinical outcomes, enhanced patient satisfaction, reduced healthcare utilization, and stronger interdisciplinary collaboration. As healthcare continues to embrace digital transformation, insulin pump technology will remain an essential component of evidence-based diabetes management and high-quality nursing care.